Generic Name and Formulations:
Carisoprodol 200mg, aspirin 325mg; tabs.
Various generic manufacturers
- Pharmacogenomics for Pain Management: When Should It Be Used?
- Opioid Use Increases Risk of Cardiac Events in Older Patients With COPD
- Integrative Therapies for Breast Cancer Treatment: Clinical Practice Guideline
Indications for Carisoprodol/Aspirin:
Painful musculoskeletal conditions.
1–2 tabs 4 times daily.
NSAID allergy. Varicella or influenza in teenagers. Coagulation disorders. Porphyria.
Peptic ulcer. Gastritis. Renal or hepatic dysfunction. Drug abuse. Monitor blood pressure, BUN, uric acid levels. Elderly. Debilitated. Pregnancy (Cat.C). Nursing mothers: not recommended.
Alcohol, CNS depressants, oral anticoagulants, hypoglycemics, and plasma bound drugs (e.g., methotrexate) potentiated. NSAIDs, corticosteroids and oral anticoagulants increase risk of GI bleeding. Uricosurics antagonized. Urine alkalinizers or acidifiers decrease or increase, respectively, plasma levels of aspirin.
Muscle relaxant (central) + salicylate.
Dizziness, drowsiness, GI upset or bleeding, rash, tachycardia, orthostatic hypotension. Rare idiosyncratic reaction (see literature).
Formerly known under the brand name Soma Compound.
Clinical Pain Advisor Articles
- Brain Plasticity in Patients With Complex Regional Pain Syndrome
- Chronic Pain Associated With Traumatic Brain Injury: Causes and Management
- Perturbation-Based Rehabilitation Effective for Chronic Low Back Pain
- Migraine Frequency Correlated With Depression and Anxiety
- IBS-Associated Chronic Pain: Formulation of Core Diagnostic Criteria
- Cannabis Use Associated With Aberrant Drug Behaviors
- Walgreens to Carry Naloxone in All Pharmacies to Combat Drug Abuse
- Independent Pharmacies Expanding Services Available to Patients
- Ketamine Exhibits Effective Pain Relief for Refractory Headaches
- Pain In Elite Athletes: IOC Recommendations on Contributing Factors and Treatment Approach
- Pain Processing: Examining the Role of Oxytocin
- Short- vs Long-Acting Opioids for Osteoarthritis Pain
- Extended-Release Naltrexone Injections Reduce Opioid Dependence
- Depressive Symptoms Among Medical Interns Increased With Work-Family Conflicts
- CMS Launches Initiative to Analyze Regulation Impact on Patient Care